Boston Scientific to Sell $1 Billion in Debt

According to a report on the Boston Business Journal, Natick-Based Boston Scientific will be offering to sell their debt for payments due down the road.

"The medical device company said Friday it will issue the new notes in two tranches — a $600 million offering due in 2018 and a $450 million offering that matures in 2023. The company plans to use proceeds from the sale to retire existing long-term debt, much of which stems from the Guidant deal.